HIV type 1 resistance in Kenyan sex workers is not associated with altered cellular susceptibility to HIV type 1 infection or enhanced β-chemokine production

被引:56
作者
Fowke, KR
Dong, T
Rowland-Jones, SL
Oyugi, J
Rutherford, WJ
Kimani, J
Krausa, P
Bwayo, J
Simonsen, JN
Shearer, GM
Plummer, FA
机构
[1] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA
[2] John Radcliffe Hosp, Inst Mol Med, Mol Immunol Grp, Oxford OX3 9DS, England
[3] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya
[4] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 0W3, Canada
关键词
D O I
10.1089/aid.1998.14.1521
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A small group of women (n = 80) within the Nairobi-based Pumwani Sex Workers Cohort demonstrates epidemiologic resistance to HIV-1 infection. Chemokine receptor polymorphisms and beta-chemokine overproduction have been among the mechanisms suggested to be responsible for resistance to HIV-1 infection, This study attempts to determine if any of those mechanisms are protecting the HIV-1-resistant women. Genetic analysis of CCR5 and CCR3 from the resistant women demonstrated no polymorphisms associated with resistance. Expression levels of CCR5 among the resistant women were shown to be equivalent to that found in low-risk seronegative (negative) controls, while CXCR4 expression was greater among some of the resistant women. In vitro infection experiments showed that phytohemagglutinin (PHA)-stimulated peripheral blood mononuclear cells (PBMCs) from resistant women mere as susceptible to infection to T cell- and macrophage-tropic North American and Kenyan HIV-1 isolates as were the PBMCs from negative controls, No significant difference in circulating plasma levels of MIP-1 alpha and MIP-1 beta were found between the resistant women and negative or HIV-1-infected controls. In vitro cultures of media and PHA-stimulated PBMCs indicated that the resistant women produced significantly less MIP-1 alpha and MIP-1 beta than did negative controls and no significant difference in RANTES levels were observed. In contrast to studies in Caucasian cohorts, these data indicate that CCR5 polymorphisms, altered CCR5 and CXCR4 expression levels, cellular resistance to in vitro HIV-1 infection, and increased levels of beta-chemokine production do not account for the resistance to HIV-1 infection observed among the women of the Pumwani Sex Workers Cohort.
引用
收藏
页码:1521 / 1530
页数:10
相关论文
共 54 条
[31]   HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals [J].
Mazzoli, S ;
Trabattoni, D ;
Caputo, SL ;
Piconi, S ;
Ble, C ;
Meacci, F ;
Ruzzante, S ;
Salvi, A ;
Semplici, F ;
Longhi, R ;
Fusi, ML ;
Tofani, N ;
Biasin, M ;
Villa, ML ;
Mazzotta, F ;
Clerici, M .
NATURE MEDICINE, 1997, 3 (11) :1250-1257
[32]   The role of CCR5 and CCR2 polymorphisms in HTV-1 transmission and disease progression [J].
Michael, NL ;
Louie, LG ;
Rohrbaugh, AL ;
Schultz, KA ;
Dayhoff, DE ;
Wang, CE ;
Sheppard, HW .
NATURE MEDICINE, 1997, 3 (10) :1160-1162
[33]   ANALYSIS OF ANY POINT MUTATION IN DNA - THE AMPLIFICATION REFRACTORY MUTATION SYSTEM (ARMS) [J].
NEWTON, CR ;
GRAHAM, A ;
HEPTINSTALL, LE ;
POWELL, SJ ;
SUMMERS, C ;
KALSHEKER, N ;
SMITH, JC ;
MARKHAM, AF .
NUCLEIC ACIDS RESEARCH, 1989, 17 (07) :2503-2516
[34]   Cloning and characterization of a novel promiscuous human β-chemokine receptor D6 [J].
Nibbs, RJB ;
Wylie, SM ;
Yang, JY ;
Landau, NR ;
Graham, GJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (51) :32078-32083
[35]   Inhibition of HIV-1 infection by the beta-chemokine MDC [J].
Pal, R ;
GarzinoDemo, A ;
Markham, PD ;
Burns, J ;
Brown, M ;
Gallo, RC ;
DeVico, AL .
SCIENCE, 1997, 278 (5338) :695-698
[36]   Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures [J].
Paxton, WA ;
Martin, SR ;
Tse, D ;
OBrien, TR ;
Skurnick, J ;
VanDevanter, NL ;
Padian, N ;
Braun, JF ;
Kotler, DP ;
Wolinsky, SM ;
Koup, RA .
NATURE MEDICINE, 1996, 2 (04) :412-417
[37]   COFACTORS IN MALE-FEMALE SEXUAL TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
PLUMMER, FA ;
SIMONSEN, JN ;
CAMERON, DW ;
NDINYAACHOLA, JO ;
KREISS, JK ;
GAKINYA, MN ;
WAIYAKI, P ;
CHEANG, M ;
PIOT, P ;
RONALD, AR ;
NGUGI, EN .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (02) :233-239
[38]   Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils [J].
Ponath, PD ;
Qin, SX ;
Post, TW ;
Wang, J ;
Wu, L ;
Gerard, NP ;
Newman, W ;
Gerard, C ;
Mackay, CR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (06) :2437-2448
[39]   Phylogenetic evaluation of Kenyan HIV type 1 isolates [J].
Poss, M ;
Gosink, J ;
Thomas, E ;
Kreiss, JK ;
NdinyaAchola, J ;
Mandaliya, K ;
Bwayo, J ;
Overbaugh, J .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (06) :493-499
[40]   Antigen-specific release of β-chemokines by anti-HIV-1 cytotoxic T lymphocytes [J].
Price, DA ;
Sewell, AK ;
Dong, T ;
Tan, RS ;
Goulder, PJR ;
Rowland-Jones, SL ;
Phillips, RE .
CURRENT BIOLOGY, 1998, 8 (06) :355-358